NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹227 Cr | ₹216 Cr | ₹311 Cr | ₹340 Cr | ₹351 Cr |
What is the latest Net Current Assets ratio of NECTAR LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹227 Cr |
| Mar2025 | ₹216 Cr |
| Mar2024 | ₹311 Cr |
| Mar2023 | ₹340 Cr |
| Mar2022 | ₹351 Cr |
How is Net Current Assets of NECTAR LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹227 Cr | 5.03 | |
| Mar2025 | ₹216 Cr | -30.54 | |
| Mar2024 | ₹311 Cr | -8.59 | |
| Mar2023 | ₹340 Cr | -3.07 | |
| Mar2022 | ₹351 Cr | - | |
Compare Net Current Assets of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹197.0 Cr | 1.1% | -1.2% | -31.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 1.1% |
-1.2% |
-31.9% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses